$SQZ SQZ Biotechnologies Co Insider Trading
Get free email notifications about insider trading in SQZ Biotechnologies Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SQZ Biotechnologies Co. Insider overview, share value development, latest insider transactions and email notifications about new events in SQZ Biotechnologies Co for free.
CIK Number: 0001604477
IRS Number: 462431115
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: SQZ
Company Address: 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN 02472
Phone number: 617-898-8824
SQZ Biotechnologies Co Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | SQZ | SQZ Biotechnologie ... | Sharei Armon | President and CEO | Option Exercise | M | 1.81 | 8,000 | 14,480 | 195,986 | |
Mar 02 2021 | SQZ | SQZ Biotechnologie ... | Sharei Armon | President and CEO | Buy | M | 1.81 | 8,000 | 14,480 | 259,713 | 251.7 K to 259.7 K (+3.18 %) |
Feb 25 2021 | SQZ | SQZ Biotechnologie ... | BERNSTEIN HOWARD PHD MD | Chief Scientific Of ... | Option Exercise | A | 16.85 | 72,900 | 1,228,365 | 72,900 | |
Feb 25 2021 | SQZ | SQZ Biotechnologie ... | Loxam Teri | Chief Financial Off ... | Option Exercise | A | 16.85 | 75,950 | 1,279,758 | 75,950 | |
Feb 25 2021 | SQZ | SQZ Biotechnologie ... | Sharei Armon | President and CEO | Option Exercise | A | 16.85 | 195,000 | 3,285,750 | 195,000 | |
Nov 02 2020 | SQZ | SQZ Biotechnologie ... | AMERICAN INTERNATIONAL GROUP I ... | 10% Owner | Option Exercise | C | 0.00 | 66,803 | 0 | 0 | |
Nov 02 2020 | SQZ | SQZ Biotechnologie ... | AMERICAN INTERNATIONAL GROUP I ... | 10% Owner | Option Exercise | C | 0.00 | 36,937 | 0 | 0 | |
Nov 02 2020 | SQZ | SQZ Biotechnologie ... | AMERICAN INTERNATIONAL GROUP I ... | 10% Owner | Option Exercise | C | 0.00 | 1,435,079 | 0 | 0 | |
Nov 02 2020 | SQZ | SQZ Biotechnologie ... | AMERICAN INTERNATIONAL GROUP I ... | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 625,000 | 0 to 625 K |
Nov 02 2020 | SQZ | SQZ Biotechnologie ... | AMERICAN INTERNATIONAL GROUP I ... | 10% Owner | Buy | C | 0.00 | 70,344 | 0 | 70,344 | 0 to 70.3 K |
Nov 02 2020 | SQZ | SQZ Biotechnologie ... | AMERICAN INTERNATIONAL GROUP I ... | 10% Owner | Buy | C | 0.00 | 38,895 | 0 | 38,895 | 0 to 38.9 K |
Nov 02 2020 | SQZ | SQZ Biotechnologie ... | AMERICAN INTERNATIONAL GROUP I ... | 10% Owner | Buy | C | 0.00 | 1,511,139 | 0 | 1,511,139 | 0 to 1.5 M |
Oct 30 2020 | SQZ | SQZ Biotechnologie ... | Moessinger Eric | Director | Option Exercise | A | 16.00 | 7,055 | 112,880 | 7,055 | |
Oct 30 2020 | SQZ | SQZ Biotechnologie ... | Garg Pushkal | Director | Option Exercise | A | 16.00 | 7,055 | 112,880 | 7,055 | |
Oct 30 2020 | SQZ | SQZ Biotechnologie ... | Jensen Klavs F. | Director | Option Exercise | A | 16.00 | 7,055 | 112,880 | 7,055 |